{"id":"W1546666727","doi":"10.1111/j.1365-2036.2010.04427.x","title":"Meta‐analysis: re‐treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Vertex Pharmaceuticals; Intarcia Therapeutics; Gilead Sciences; Valeant Pharmaceuticals International; Pfizer","keywords":"Ribavirin; Medicine; Internal medicine; Combination therapy; Gastroenterology; Pegylated interferon; Hepatitis C; Randomized controlled trial; Hepatitis C virus; Population; Alpha interferon; Immunology; Interferon; Virus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02444571,0.00349765,0.02089604,0.004238396,0.0005508714,0.003941958,0.002127647,0.002702169,0.003684988],"category_scores_gemma":[0.04083821,0.001322619,0.06118046,0.003840013,0.0007351545,0.001855772,0.001231066,0.003027953,0.0003317192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002138816,"about_ca_system_score_gemma":0.001448788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004403559,"about_ca_topic_score_gemma":0.005620786,"domain_scores_codex":[0.9774904,0.0159648,0.003299393,0.001785253,0.001078942,0.0003811247],"domain_scores_gemma":[0.972535,0.02166859,0.003264251,0.001286692,0.0009426512,0.0003028508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.006207197,0.00002538576,0.002313175,0.04221006,0.9433675,0.00008408482,0.00002652843,0.0007605825,0.0001577836,0.00006386437,0.0003927014,0.004391074],"study_design_scores_gemma":[0.001631079,0.0002583379,0.001838471,0.002596948,0.9923182,0.00006416375,0.00001646972,0.0004359241,0.0001012822,0.000173065,0.0005514868,0.00001455848],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02262411,0.9718617,0.002068532,0.0005500843,0.0006721749,0.0005112243,0.0008494073,0.0001113798,0.0007513858],"genre_scores_gemma":[0.7278289,0.2600406,0.004819041,0.002300016,0.0007985348,0.001384818,0.001710815,0.000113066,0.001004258],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02444571,"threshold_uncertainty_score":0.1292828,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2101921882283772,"score_gpt":0.4412999371621188,"score_spread":0.2311077489337416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}